Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...

Three That Doubled, Three More That May Double.

Ardelyx $3.00 (ARDX) Gains 117%, Provention Bio $8.75 (PRVB) Gains 134%, and PharmaTher (PHRRF) up 154%. Blue Skies Ahead - For All...

Initiating Coverage on Society Pass (SOPA).

Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley

Society Pass (SOPA) Research Reports

RESEARCH REPORT ARCHIVE December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.

Adding Society Pass (SOPA) $0.96 to the Watch List

Amazing Fast Grower, in the Asian Silicon Valley. After a wildly successful IPO debut and subsequent tumble, Society...

Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.

Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm. Atai was founded in...

Ouch, for Now. Progressive Care Does 200:1 Reverse.

MASSIVE REVERSE SPLIT Let's just watch from the sidelines for...

Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!

And We Weren't Watching! It was Friday after all, and the last day of the year, and we were...

He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!

Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...